Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2010 3
2011 3
2012 6
2013 5
2014 2
2015 1
2016 5
2017 1
2018 3
2019 7
2020 3
2021 5
2022 8
2023 4
2024 10
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Understanding the role of NOTCH2 mutation in centronuclear myopathy.
Lin Y, Zhou H, Hu W, Gao B, Liang T, Qiu J, Li P, Que Y, Wong C, Qiu X, Deng Z, Shi H, Liu S, Chen J, Liao N, Chen Q, Li X, Liang A, Gao W, Huang D. Lin Y, et al. Among authors: liang a. Mol Ther. 2025 Aug 6;33(8):3718-3732. doi: 10.1016/j.ymthe.2025.04.041. Epub 2025 May 6. Mol Ther. 2025. PMID: 40336196
Corrigendum to "IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling" [Int. Immunopharmacol. 141 (2024) 112966].
Li P, Que Y, Wong C, Lin Y, Qiu J, Gao B, Zhou H, Hu W, Shi H, Peng Y, Huang D, Gao W, Qiu X, Liang A. Li P, et al. Among authors: liang a. Int Immunopharmacol. 2025 Jan 27;146:113907. doi: 10.1016/j.intimp.2024.113907. Epub 2024 Dec 25. Int Immunopharmacol. 2025. PMID: 39725593 Free article. No abstract available.
Corrigendum to "IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling" [Int. Immunopharmacol. 141 (2024) 112966].
Li P, Que Y, Wong C, Lin Y, Qiu J, Gao B, Zhou H, Hu W, Shi H, Peng Y, Huang D, Gao W, Qiu X, Liang A. Li P, et al. Among authors: liang a. Int Immunopharmacol. 2024 Dec 5;142(Pt A):113049. doi: 10.1016/j.intimp.2024.113049. Epub 2024 Sep 17. Int Immunopharmacol. 2024. PMID: 39294029 No abstract available.
64 results